Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
NCT04974970
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
early termination due to insufficient recruitment
Conditions
Food Allergy
Peanut Allergy
Interventions
DRUG:
Peanut Immunotherapy
Sponsor
University Hospital, Geneva